Latest News & Features
Americas
Biogen and Forward Pharma, a Denmark-based company, have entered into a settlement and licensing agreement under which Biogen will pay Forward Pharma $1.25 billion. 19 January 2017
Americas
Mallinckrodt ARD, formerly known as Questcor Pharmaceuticals, and its parent company, Mallinckrodt, will pay $100 million in a settlement over antitrust charges made by the Federal Trade Commission. 19 January 2017
Americas
The Federal Trade Commission and the Department of Justice have issued an update to the Antitrust Guidelines for Licensing of Intellectual Property, modernising the 1995 guidelines. 18 January 2017
Americas
Teva has sued Mylan for alleged patent infringement over Copaxone, a treatment for patients with relapsing-remitting forms of multiple sclerosis. 18 January 2017
Biotechnology
UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR. 17 January 2017
Americas
Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement. 17 January 2017
Big Pharma
The English High Court has referred a supplementary protection certificate dispute over Truvada to Europe’s highest court, the Court of Justice of the European Union. 16 January 2017
Americas
The US Supreme Court has agreed to hear the biosimilars dispute between Amgen and Sandoz. 16 January 2017
Americas
Sanofi and Genzyme have filed a complaint against Mylan for patent infringement over the drug Aubagio, a treatment for relapsing forms of multiple sclerosis. 13 January 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling by a district court giving a win to Eli Lilly in a patent case against Teva. 13 January 2017